Creating a facility for large-scale production of biomaterials for infectious disease research

Biomaterial Manufacturing Suite in Support of NIH/NIAID and the Global Infectious Disease Research Community

NIH-funded research American Type Culture Collection · NIH-10795293

This study is creating a special facility to make important materials quickly for researchers studying infectious diseases, helping them work better on finding solutions for outbreaks that affect public health.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAmerican Type Culture Collection NIH-funded
Lab location1 site (Manassas, United States)
Project IDNIH-10795293 on NIH RePORTER

What this research studies

This project aims to build a Biomaterial Manufacturing Suite (BMS) within a High Containment Facility to support the production of biomaterials for infectious diseases. The BMS will enable the rapid development and large-scale manufacturing of materials needed for research on priority pathogens, which are critical for public health. By providing well-characterized challenge materials at no cost, this facility will enhance the capabilities of researchers working on epidemic and pandemic threats. The project focuses on optimizing the growth and characterization of pathogenic organisms to facilitate better research outcomes.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research include individuals affected by infectious diseases or those at risk of epidemic outbreaks.

Not a fit: Patients with non-infectious diseases or conditions unrelated to the pathogens being studied may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly improve the availability of essential biomaterials for infectious disease research, leading to faster development of treatments and vaccines.

How similar studies have performed: Other research initiatives have successfully established similar facilities, indicating a proven approach to enhancing infectious disease research capabilities.

Where this research is happening

Manassas, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Infectious Diseases ResearchInfectious Diseases / LaboratoryNational Institute of Allergy and Infectious Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.